Document Detail


Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
MedLine Citation:
PMID:  12487525     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Neisseria gonorrhoeae is a major cause of pelvic inflammatory disease, ectopic pregnancy, and infertility, and it can facilitate human immunodeficiency virus (HIV) transmission. Gonorrhea is the second most frequently reported communicable disease in the United States, with 361,705 reported cases in 2001. During the 1980s, gonococcal resistance to penicillin and tetracycline became widespread; as a result, CDC recommended using cephalosporins as first-line treatment for gonorrhea. Since 1993, CDC also has recommended using fluoroquinolones (i.e., ciprofloxacin, ofloxacin, or levofloxacin) for gonorrhea treatment. Fluoroquinolone therapy is used widely because it is a relatively inexpensive, oral, and single-dose therapy. However, fluoroquinolone-resistant N. gonorrhoeae (QRNG) is being identified more frequently. This report summarizes investigations of increases in QRNG in Hawaii and California in 2001 and provides data to support the recommendation that cephalosporins (i.e., ceftriaxone or cefixime) be used instead of fluoroquinolones as first-line treatment for gonorrhea acquired in these two states. The increases in QRNG highlight the importance of monitoring gonococcal resistance throughout the United States to guide local treatment decisions.
Authors:
Related Documents :
3137965 - Gonococcal and chlamydial antibodies in ectopic and intrauterine pregnancy.
4072965 - Immunohistochemical demonstration of placental hormones in the diagnosis of uterine ver...
2882185 - Local prostaglandin f2 alpha injection for termination of ectopic pregnancy.
23337725 - Placental specific mrna in the maternal circulation are globally dysregulated in pregna...
3137965 - Gonococcal and chlamydial antibodies in ectopic and intrauterine pregnancy.
9160385 - Early ultrasound prediction of pregnancies affected by homozygous alpha-thalassaemia-1.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  MMWR. Morbidity and mortality weekly report     Volume:  51     ISSN:  0149-2195     ISO Abbreviation:  MMWR Morb. Mortal. Wkly. Rep.     Publication Date:  2002 Nov 
Date Detail:
Created Date:  2002-12-18     Completed Date:  2002-12-24     Revised Date:  2008-02-14    
Medline Journal Info:
Nlm Unique ID:  7802429     Medline TA:  MMWR Morb Mortal Wkly Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1041-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Infective Agents / pharmacology*
California / epidemiology
Cephalosporins / therapeutic use
Drug Resistance, Bacterial*
Fluoroquinolones
Gonorrhea / drug therapy,  epidemiology,  microbiology*
Hawaii / epidemiology
Humans
Neisseria gonorrhoeae / drug effects*
Chemical
Reg. No./Substance:
0/Anti-Infective Agents; 0/Cephalosporins; 0/Fluoroquinolones
Comments/Corrections
Comment In:
Ann Emerg Med. 2003 May;41(5):744-8   [PMID:  12712045 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Head injury with traumatic and postural asphyxia: a case report.
Next Document:  Multistate outbreaks of Salmonella serotype Poona infections associated with eating cantaloupe from ...